Skip to main navigation Skip to search Skip to main content

Non-canonical Golgi-compartmentalized Gβγ signaling: mechanisms, functions, and therapeutic targets

Research output: Contribution to journalReview articlepeer-review

Abstract

G protein Gβγ subunits are key mediators of G protein-coupled receptor (GPCR) signaling under physiological and pathological conditions; their inhibitors have been tested for the treatment of human disease. Conventional wisdom is that the Gβγ complex is activated and subsequently exerts its functions at the plasma membrane (PM). Recent studies have revealed non-canonical activation of Gβγ at intracellular organelles, where the Golgi apparatus is a major locale, via translocation or local activation. Golgi-localized Gβγ activates specific signaling cascades and regulates fundamental cell processes such as membrane trafficking, proliferation, and migration. More recent studies have shown that inhibiting Golgi-compartmentalized Gβγ signaling attenuates cardiomyocyte hypertrophy and prostate tumorigenesis, indicating new therapeutic targets. We review novel activation mechanisms and non-canonical functions of Gβγ at the Golgi, and discuss potential therapeutic interventions by targeting Golgi-biased Gβγ-directed signaling.

Original languageEnglish (US)
Pages (from-to)98-111
Number of pages14
JournalTrends in Pharmacological Sciences
Volume44
Issue number2
DOIs
StatePublished - Feb 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • G proteins
  • GPCRs
  • Golgi apparatus
  • Gβγ
  • MAPK
  • PKD
  • cardiac hypertrophy
  • oncogenic signaling
  • therapeutic target
  • translocation

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Fingerprint

Dive into the research topics of 'Non-canonical Golgi-compartmentalized Gβγ signaling: mechanisms, functions, and therapeutic targets'. Together they form a unique fingerprint.

Cite this